RxDoctor Payments Data

Suleman Hussain, MD

Sports Medicine · Bettendorf, IANPI 1902062227

Payments from drug & device makers

What this record shows

This record is dominated by education: $1,021 of the $1,361 with a category attached, or 75.0%. Zimmer Biomet accounts for 75.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $1,108 and has fallen 86.7% since, to $148 in 2025. That places this record below the midpoint for sports medicine clinicians in IA, where the typical reported total is $1,337.

$1,361in general payments, 2019–2025

Across 8 payments — averaging $170.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$1K
  • Stryker$145
  • Prism Medical$123
  • Medical Device Business Services, Inc.$34
  • Asahi Intecc USA, Inc.$25
  • Pfizer$13

What the payments were for

  • Food & beverage$34025%
  • Education$1,02175%

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet2$1,021
Stryker2$145
Prism Medical1$123
Medical Device Business Services, Inc.1$34
Asahi Intecc USA, Inc.1$25
Pfizer1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,361 in reported general payments places this provider in the 50th percentile of 33 sports medicine providers in Iowa.

See all sports medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$345,880
Medicare patients
637
Services billed
8,763

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban66$18,112
Gabapentin241$1,834
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen201$1,563
Tranexamic Acid154$1,278
Ondansetron OdtOndansetron184$994
Doxycycline Hyclate59$703
Meloxicam208$650
Famotidine121$544
Diclofenac Sodium23$502
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen75$457
Methylprednisolone80$434
Amoxicillin224$209
Cephalexin42$155
Clindamycin Hcl53$76
Tramadol Hcl31$49

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$18,11266 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 33 sports medicine providers in Iowa.

Other sports medicine in Bettendorf

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →